These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Long-acting beta2-agonists versus placebo in addition to inhaled corticosteroids in children and adults with chronic asthma. Ni Chroinin M, Greenstone IR, Danish A, Magdolinos H, Masse V, Zhang X, Ducharme FM. Cochrane Database Syst Rev; 2005 Oct 19; (4):CD005535. PubMed ID: 16235410 [Abstract] [Full Text] [Related]
11. Drug utilization and asthma control among young Danish adults with asthma. Analyses of trends and determinants. Davidsen JR. Dan Med J; 2012 Aug 19; 59(8):B4501. PubMed ID: 22849986 [Abstract] [Full Text] [Related]
16. Treatment of Medicaid patients with asthma: comparison with treatment guidelines using disease-based drug utilization review methodology. Laumann JM, Bjornson DC. Ann Pharmacother; 1998 Dec 19; 32(12):1290-4. PubMed ID: 9876808 [Abstract] [Full Text] [Related]
17. Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma. Ducharme FM, Lasserson TJ, Cates CJ. Cochrane Database Syst Rev; 2006 Oct 18; (4):CD003137. PubMed ID: 17054161 [Abstract] [Full Text] [Related]
19. The use of beta 2-adrenoceptor agonists in the treatment of bronchial asthma. Svedmyr N, Löfdahl CG. Pharmacol Toxicol; 1996 Jan 18; 78(1):3-11. PubMed ID: 8685084 [Abstract] [Full Text] [Related]